Advertisement

Topics

Epizyme collaborates with Foundation Medicine for Phase II trial of tazemetostat

19:00 EDT 21 Sep 2016 | Net Resources International

US-based clinical-stage biopharmaceutical company Epizyme has collaborated with genomic analysis diagnostics firm Foundation Medicine to support patient identification and enrolment for its ongoing Phase II clinical trial of tazemetostat in patients …

Original Article: Epizyme collaborates with Foundation Medicine for Phase II trial of tazemetostat

NEXT ARTICLE

More From BioPortfolio on "Epizyme collaborates with Foundation Medicine for Phase II trial of tazemetostat"

Quick Search
Advertisement